Skip to content

Clinical observation of Yushentongluo Granule combined with clomiphene in the treatment of anovulatory infertility

Clinical observation of Yushentongluo Granule combined with clomiphene in the treatment of anovulatory infertility

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040753
Enrollment
Unknown
Registered
2020-12-08
Start date
2016-08-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anovulatory infertility

Interventions

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria of anovulatory infertility and syndrome differentiation of traditional Chinese medicine; (2) Those aged 20-40 years; (3) Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Infertility caused by congenital genital defects or deformities; (2) Infertility caused by genetic factors; (3) Endometriosis, adenomyosis, hysteromyoma and hypoplasia were confirmed by examination; (4) Infertility caused by fallopian tube obstruction; (5) Immune infertility; (6) Male reproductive function was abnormal; (7) Those who have used hormone drugs in the past 3 months; (8) Patients with severe diseases such as cardiovascular, liver, kidney, immune system, hematopoietic system, psychosis, and other organ system dysfunction.

Design outcomes

Primary

MeasureTime frame
endometrial thickness;follicular development;pregnancy;

Secondary

MeasureTime frame
basal?body?temperature;TCM syndrome score;

Countries

China

Contacts

Public ContactXu Hua-Yun

Shanghai General Hospital

bullforg_xu@126.com+86 13041683560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026